iShares MSCI China ETF vs RLX Technology Inc — how do they compare? iShares MSCI China ETF trades at $52.53 (market cap $5.94B), while RLX Technology Inc trades at $1.74 (market cap $2.10B). The key difference: iShares MSCI China ETF is far larger — about 2.8× RLX Technology Inc's market cap, and RLX Technology Inc pays a 5.81% dividend while iShares MSCI China ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold iShares MSCI China ETF for 63 Days and RLX Technology Inc for 35 Days on average.
| MCHI | RLX | |
|---|---|---|
Market Cap | $5.94B | $2.10B |
Volume | 1,575,471 | 1,079,706 |
Sector | Broad Market / Factor | Consumer Staples |
52-Week High | $65.59 | $2.57 |
52-Week Low | $50.48 | $1.68 |
Typical Hold Time | 63 Days | 35 Days |
Enterprise Value | — | $832.26M |
Dividend Yield | — | 5.81% |
Signals from Pluang's Aura AI — not financial advice
MCHI trades at $52.46, up 1.59% today, but faces strong bearish technical signals with 13 sell signals on moving averages. The ETF's valuation remains historically cheap compared to US indices, with Seeking Alpha noting the discount despite significant tech exposure. Recent news highlights China's economic challenges including industrial overcapacity and trade tensions ahead of key US-China meetings.
Outlook remains cautious given bearish technicals and China's macroeconomic headwinds, though the valuation discount presents potential opportunity. Key risks include US-China trade tensions and weak domestic consumption. Institutional activity shows mixed signals with recent purchases by Empowered Funds offset by sales from Acima Private Wealth.
RLX Technology trades at $1.735, up 0.29% with bearish technical signals despite recent 52-week lows. The company shows solid fundamentals with $3.62B revenue, 21.87% net margin, and attractive valuation at P/E 15.46 and P/B 0.91. Recent earnings missed expectations but international expansion drives growth, with 70% revenue now from overseas markets. Cash flow trends improved significantly from -$99M in 2025 to $881M projected for 2026.
RLX presents a value opportunity with discounted valuation and strong international growth, though technical weakness and earnings misses warrant caution. The single analyst coverage maintains Hold rating, reflecting uncertainty amid expansion execution risks and regulatory challenges in the e-vapor industry.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
MCHI is an ETF that seeks to track the investment results of the MSCI China Index. It provides broad exposure to the Chinese equity market, primarily focusing on large and mid-cap companies listed in Hong Kong and Shanghai. MCHI serves as a core holding for investors looking to gain diversified exposure to the performance and growth potential of the companies within the People's Republic of China.
Read more on MCHI →RLX Technology Inc. is a leading e-vapor company in China, focusing on the research, development, and sale of e-vapor products. The company primarily operates under the RELX brand, offering a range of closed-system e-vapor products designed to deliver a high-quality user experience. RLX's business model is centered on product innovation, strong brand building, and a vast distribution network across China.
Read more on RLX →